These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 16267247)
41. Duchenne muscular dystrophy: issues in expanding newborn screening. Kemper AR; Wake MA Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940 [TBL] [Abstract][Full Text] [Related]
42. Evidence-based drug treatment of heart failure. Wasson S; Fleming D; Reddy HK Mo Med; 2005; 102(6):540-8; quiz 548-9. PubMed ID: 16355640 [TBL] [Abstract][Full Text] [Related]
43. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Jahns R; Boivin V; Lohse MJ Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696 [TBL] [Abstract][Full Text] [Related]
44. Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs. Colan SD Circulation; 2005 Nov; 112(18):2756-8. PubMed ID: 16267247 [No Abstract] [Full Text] [Related]
45. Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review. Haddad CN; Ali S; Stephanou D; Assakura MS; Sahagian L; Trogkanis E Hellenic J Cardiol; 2023; 74():58-64. PubMed ID: 37406964 [TBL] [Abstract][Full Text] [Related]
46. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. Kaspar RW; Allen HD; Montanaro F J Am Acad Nurse Pract; 2009 May; 21(5):241-9. PubMed ID: 19432907 [TBL] [Abstract][Full Text] [Related]
48. Up to date in pharmacological treatment of dilated cardiomyopathy. Ginghina C; Teodorescu A; Stoian I; Serban M; Ghiorghiu I; Wohlfart K Rom J Intern Med; 2004; 42(1):3-13. PubMed ID: 15529591 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]